IMPACT: Implantable Microsystems for Personalised Anti-Cancer Therapy

IMPACT is a 5-year, £5.2M research project, funded by an EPSRC Programme Grant, to develop new approaches to cancer treatment, using implanted, smart sensors on silicon, fabricated in the University's Scottish Microelectronics Centre. IMPACT will use miniaturised, wireless sensor chips the size of a grass seed to monitor the minute-to-minute status of an individual tumour. This will allow RT to be targeted in space and time to damage cancer cells as much as possible. The team consists of engineers, chemists, veterinary clinicians, social scientists and human cancer specialists, led by Prof Alan Murray from the University's School of Engineering.

 

IMPACT must integrate radically new sensors on silicon with the instrumentation, control and communications that they require. The final choice of sensor technologies will depend upon;

  • sensor responses and calibration
  • the size of the implanted device
  • techniques to place sensors on standard chips
  • chip "packaging" technology for long term implantation

Initially, the system will be developed as a set of individual chips. The final system will integrate sensors, instrumentation and communications on a single device.

Implantable Microsystems for Personalised Anti-Cancer Therapy logo
Implantable Microsystems for Personalised Anti-Cancer Therapy
Implantable Microsystems for Personalised Anti-Cancer Therapy
Stereotactic insertion of microchips

Project Website: 

Principal Investigator: 

Professor Alan Murray

Research Institutes: 

  • Bioengineering

Research Themes: 

  • Bioengineering
Thursday, August 28, 2014 - 11:06